Pharmaceutically Acceptable Salts of Thymodepressin and Processes for their Manufacture
申请人:Tam Tim Fat
公开号:US20100056803A1
公开(公告)日:2010-03-04
The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D- tryptophan organic ammonium salts (1:1).
Bar soaps containing polyhydroxy fatty acid amides exhibit good "smear" qualities, desirable hardness and good lather properties. The bars also have a decreased tendency to crack. Bars comprising soap and materials such as C.sub.12 -C.sub.18 N-methyl glucamide are provided.
Proteins which modulate body weight of animals and humans for the treatment, prevention and control of obesity and associated diseases or conditions, and the recombinant expression of these biologically active proteins in purified and homogeneous forms.